Adults with advanced NSCLC and performance status of @ to @ , who were not treated with chemotherapy or radiotherapy within the last @ weeks , were randomly assigned to daily modafinil ( @ mg on days @ to @ ; @ mg on days @ to @ ) or matched placebo .